2026-04-27T01:59:30Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/174772024-09-27T19:23:41Zcom_20.500.12105_2052com_20.500.12105_2051col_20.500.12105_19609

00925njm 22002777a 4500 dc Thompson, George R author Le, Thuy author Chindamporn, Ariya author Kauffman, Carol A author Alastruey-Izquierdo, Ana author Ampel, Neil M author Andes, David R author Armstrong-James, Darius author Ayanlowo, Olusola author Baddley, John W author Barker, Bridget M author Lopes Bezerra, Leila author Buitrago, Maria Jose author Chamani-Tabriz, Leili author Chan, Jasper F W author Chayakulkeeree, Methee author Cornely, Oliver A author Cunwei, Cao author Gangneux, Jean-Pierre author Govender, Nelesh P author Hagen, Ferry author Hedayati, Mohammad T author Hohl, Tobias M author Jouvion, Grégory author Kenyon, Chris author Kibbler, Christopher C author Klimko, Nikolai author Kong, David C M author Krause, Robert author Lee Lee, Low author Meintjes, Graeme author Miceli, Marisa H author Rath, Peter-Michael author Spec, Andrej author Queiroz-Telles, Flavio author Variava, Ebrahim author Verweij, Paul E author Schwartz, Ilan S author Pasqualotto, Alessandro C author 2021-12 The global burden of the endemic mycoses (blastomycosis, coccidioidomycosis, emergomycosis, histoplasmosis, paracoccidioidomycosis, sporotrichosis, and talaromycosis) continues to rise yearly and these infectious diseases remain a leading cause of patient morbidity and mortality worldwide. Management of the associated pathogens requires a thorough understanding of the epidemiology, risk factors, diagnostic methods and performance characteristics in different patient populations, and treatment options unique to each infection. Guidance on the management of these infections has the potential to improve prognosis. The recommendations outlined in this Review are part of the "One World, One Guideline" initiative of the European Confederation of Medical Mycology. Experts from 23 countries contributed to the development of these guidelines. The aim of this Review is to provide an up-to-date consensus and practical guidance in clinical decision making, by engaging physicians and scientists involved in various aspects of clinical management. Lancet Infect Dis. 2021 Dec;21(12):e364-e374. http://hdl.handle.net/20.500.12105/17477 34364529 10.1016/S1473-3099(21)00191-2 1474-4457 The Lancet. Infectious diseases Global guideline for the diagnosis and management of the endemic mycoses: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology